Il rapporto
Notizie verificate su finanziamenti, sedi centrali e leadership delle aziende più innovative al mondo
128 report e oltre
Doppelmayr USA Opens New Headquarters in Salt Lake City
Ropeway maker Doppelmayr USA opened a 160,000-square-foot campus in Salt Lake City that combines its new headquarters, manufacturing and training facility.
Sirona Medical Raises $40M Series D for AI-Native Radiology Workflow Software
Sirona Medical announced a $40 million Series D financing led by Avidity Partners, with participation from 8VC, GreatPoint Ventures, KLT Holdings and other investors.
OuterSignal Raises $22M Series A for Agentic Personalization
OuterSignal raised a $22 million Series A co-led by Long Journey Ventures and Abstract Ventures to build agentic personalization for consumer brands.
Altis Labs Raises $25M Series A for AI Clinical-Trial Endpoints
Altis Labs raised a $25 million Series A co-led by OrbiMed and Qiming Venture Partners USA to expand AI endpoints for oncology clinical trials.
Eltek Appoints Ron Freund Chief Executive Officer
Eltek’s board appointed CFO Ron Freund as CEO effective September 23, 2026, succeeding Eli Yaffe, who is retiring from the role.
Stoke Space Raises $1B Series E for Reusable Launch Vehicles
Stoke Space completed an initial closing of a $1 billion Series E co-led by Point72 Ventures and Spark Capital to advance its fully reusable launch vehicles and launch infrastructure.
Critical Materials Group Raises $10.3M Seed for Modular Energetics Manufacturing
Critical Materials Group raised a $10.3 million Seed round led by Overmatch Ventures to develop and commission its modular energetics production platform.
TaxHawk Opens New Headquarters on State Street in Provo
TaxHawk, the company behind FreeTaxUSA, opened a new corporate headquarters at 1255 South State Street near its long-time Provo base.
Nasus Pharma Appoints Brendan P. O’Grady Chief Executive Officer
Nasus Pharma appointed Brendan P. O’Grady Chief Executive Officer, succeeding Dan Teleman, to lead its next phase of growth with an initial focus on the commercial potential of NS002.
Visualizzazione di 9 report • Pagina 1 • Categoria: all
Rimani avanti rispetto al mercato
Ricevi insight settimanali nella tua casella di posta. Niente spam, solo intelligenza.